A phase 3 study of dorzagliatin (HMS5552) in comparison with sulfonylurea (glimepiride) and DPP-4 inhibitor (sitagliptin)
Latest Information Update: 12 Jun 2019
At a glance
- Drugs Dorzagliatin (Primary) ; Glimepiride; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
Most Recent Events
- 12 Jun 2019 New trial record
- 04 Jun 2019 According to a Hua Medicine media release, the company expects to start this study in the second half of 2019.